Literature DB >> 26385227

The development of depression-like behavior is consolidated by IL-6-induced activation of locus coeruleus neurons and IL-1β-induced elevated leptin levels in mice.

Natsuki Kurosawa1, Koh Shimizu1, Kenjiro Seki2.   

Abstract

RATIONALE: Many studies have supported the cytokine hypothesis as the underlying pathophysiology of depressive disorder.
OBJECTIVES: We previously reported that lipopolysaccharide (LPS)-induced depression-like behavior is abrogated by the α1-adrenoceptor antagonist prazosin. Since cytokines are involved in LPS effects on the brain, we investigated the effects of cytokines on noradrenergic neurons in the locus coeruleus (LC) and whether central α1-adrenoceptors can cause the development of depression-like behavior.
METHODS: Adult male CD1 mice were treated with LPS (1 mg/kg, i.p.) or saline and sacrificed 2 h later for immunofluorescence studies of c-fos and tyrosine hydroxylase (TH) expression in LC neurons. Serum cytokines were measured using enzyme-linked immunosorbent assay (ELISA). Another group of mice were implanted with intracerebroventricular (i.c.v.) cannulae and given artificial cerebrospinal fluid (CSF) (control), interleukin (IL)-1β (0.5 μg), IL-6 (1 μg), or tumor necrosis factor (TNF)-α (1 μg), and sacrificed 2 h later for c-fos and TH immunofluorescence analysis. Serum samples were analyzed for leptin levels. In addition, tail suspension test (TST), forced swimming test (FST), and sucrose preference (SP) test were conducted in a separate group of mice treated i.c.v. with cytokines, recombinant mouse leptin (5 μg) or phenylephrine (40 μg). These effects were countered by i.c.v. administration of prazosin and a leptin antagonist.
RESULTS: LPS increased c-fos expression in TH-positive neurons. Central administration of IL-6 and IL-1β increased c-fos immunoreactivity and serum leptin levels. Phenylephrine, an α1-adrenoceptor agonist, given i.c.v., increased the immobility time during FST and decreased SP, but had no effect on TST. Central leptin administration increased immobility time during FST but did not affect TST or SP. The combination of phenylephrine and leptin increased immobility time during FST and TST, and decreased SP. Induction of depression-like behavior by co-administration of IL-1β and IL-6 was prevented by pretreatment with prazosin alone.
CONCLUSION: These results suggest that IL-6-dependent LC neuronal activation induced depression-like behavior and IL-1β-induced increase in leptin levels enhanced α1-adrenoceptor-mediated depression-like behavior.

Entities:  

Keywords:  Cytokine hypothesis; Depression; Intracerebroventricular administration; Leptin; Noradrenaline; Phenylephrine; Prazosin

Mesh:

Substances:

Year:  2015        PMID: 26385227     DOI: 10.1007/s00213-015-4084-x

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  55 in total

1.  Depressive-like behavior induced by tumor necrosis factor-α in mice.

Authors:  Manuella P Kaster; Vinícius M Gadotti; João B Calixto; Adair R S Santos; Ana Lúcia S Rodrigues
Journal:  Neuropharmacology       Date:  2011-08-18       Impact factor: 5.250

2.  Elevated gene expression of glutamate receptors in noradrenergic neurons from the locus coeruleus in major depression.

Authors:  Michelle J Chandley; Attila Szebeni; Katalin Szebeni; Jessica D Crawford; Craig A Stockmeier; Gustavo Turecki; Richard M Kostrzewa; Gregory A Ordway
Journal:  Int J Neuropsychopharmacol       Date:  2014-06-13       Impact factor: 5.176

3.  Cerebrospinal cytokine levels in patients with acute depression.

Authors:  J Levine; Y Barak; K N Chengappa; A Rapoport; M Rebey; V Barak
Journal:  Neuropsychobiology       Date:  1999-11       Impact factor: 2.328

4.  IL-1 beta mediates leptin induction during inflammation.

Authors:  R Faggioni; G Fantuzzi; J Fuller; C A Dinarello; K R Feingold; C Grunfeld
Journal:  Am J Physiol       Date:  1998-01

5.  Leptin: a potential novel antidepressant.

Authors:  Xin-Yun Lu; Chung Sub Kim; Alan Frazer; Wei Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-19       Impact factor: 11.205

6.  Cytokines inhibit sexual behavior in female rats: I. Synergistic effects of tumor necrosis factor alpha and interleukin-1.

Authors:  R Avitsur; R Yirmiya
Journal:  Brain Behav Immun       Date:  1999-03       Impact factor: 7.217

7.  Systemic administration of lipopolysaccharide increases plasma leptin levels: blockade by soluble interleukin-1 receptor.

Authors:  J Francis; P S MohanKumar; S M MohanKumar; S K Quadri
Journal:  Endocrine       Date:  1999-06       Impact factor: 3.633

8.  Leptin is associated with mood status and metabolic homeostasis in patients with bipolar disorder.

Authors:  Hyun Jeong Lee; Se Hyun Kim; Eun Young Kim; Nam Young Lee; Han Young Yu; Yong Sik Kim; Yong Min Ahn
Journal:  Neuropsychobiology       Date:  2014-11-27       Impact factor: 2.328

9.  Central alpha1-adrenergic system in behavioral activity and depression.

Authors:  Eric A Stone; David Quartermain; Yan Lin; Michael L Lehmann
Journal:  Biochem Pharmacol       Date:  2006-10-05       Impact factor: 5.858

10.  The association between depression and leptin is mediated by adiposity.

Authors:  Alanna A Morris; Yusuf Ahmed; Neli Stoyanova; William Craig Hooper; Christine De Staerke; Gary Gibbons; Arshed Quyyumi; Viola Vaccarino
Journal:  Psychosom Med       Date:  2012-05-11       Impact factor: 4.312

View more
  20 in total

1.  An IL-6 receptor antagonist attenuates postpartum anhedonia, but has no effect on anhedonia precipitated by subchronic stress in female rats.

Authors:  Julie Gomez; Nicole A Haas; Jaclyn M Schwarz
Journal:  Psychopharmacology (Berl)       Date:  2019-03-04       Impact factor: 4.530

2.  The influence of central interleukin-6 on behavioral changes associated with acute alcohol intoxication in adult male rats.

Authors:  Thaddeus M Barney; Andrew S Vore; Anny Gano; Jamie E Mondello; Terrence Deak
Journal:  Alcohol       Date:  2018-11-22       Impact factor: 2.405

3.  Dihydromyricetin exerts a rapid antidepressant-like effect in association with enhancement of BDNF expression and inhibition of neuroinflammation.

Authors:  Zhaoxiang Ren; Pengju Yan; Liushuai Zhu; Huicui Yang; Yafei Zhao; Brian P Kirby; John L Waddington; Xuechu Zhen
Journal:  Psychopharmacology (Berl)       Date:  2017-10-20       Impact factor: 4.530

Review 4.  PI3K signaling: A molecular pathway associated with acute hypophagic response during inflammatory challenges.

Authors:  Beatriz C Borges; Carol F Elias; Lucila L K Elias
Journal:  Mol Cell Endocrinol       Date:  2016-07-05       Impact factor: 4.102

5.  Molecular and Functional Sex Differences of Noradrenergic Neurons in the Mouse Locus Coeruleus.

Authors:  Bernard Mulvey; Dionnet L Bhatti; Sandeep Gyawali; Allison M Lake; Skirmantas Kriaucionis; Christopher P Ford; Michael R Bruchas; Nathaniel Heintz; Joseph D Dougherty
Journal:  Cell Rep       Date:  2018-05-22       Impact factor: 9.423

6.  Immune influences on the brain: new findings and implications for treatment.

Authors:  Theodora Duka; Neil A Harrison; Oliver D Howes
Journal:  Psychopharmacology (Berl)       Date:  2016-05       Impact factor: 4.530

Review 7.  Visceral Inflammation and Immune Activation Stress the Brain.

Authors:  Peter Holzer; Aitak Farzi; Ahmed M Hassan; Geraldine Zenz; Angela Jačan; Florian Reichmann
Journal:  Front Immunol       Date:  2017-11-22       Impact factor: 7.561

8.  PI3K p110β subunit in leptin receptor expressing cells is required for the acute hypophagia induced by endotoxemia.

Authors:  Beatriz C Borges; David Garcia-Galiano; Rodrigo Rorato; Lucila L K Elias; Carol F Elias
Journal:  Mol Metab       Date:  2016-03-19       Impact factor: 7.422

9.  Depression and Inflammatory Periodontal Disease Considerations-An Interdisciplinary Approach.

Authors:  Alexandrina L Dumitrescu
Journal:  Front Psychol       Date:  2016-03-23

Review 10.  Inflammation Models of Depression in Rodents: Relevance to Psychotropic Drug Discovery.

Authors:  Jennifer L Remus; Robert Dantzer
Journal:  Int J Neuropsychopharmacol       Date:  2016-09-21       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.